L&C Bio Co., Ltd (290650.KQ)

KRW 22800.0

(-0.87%)

Net Income Summary of L&C Bio Co., Ltd

L&C Bio Co., Ltd's latest annual net income in 2023 was 48.36 Billion KRW , up 964.24% from previous year.
L&C Bio Co., Ltd's latest quarterly net income in 2024 Q2 was 1.06 Billion KRW , down -31.37% from previous quarter.
L&C Bio Co., Ltd reported an annual net income of 4.54 Billion KRW in 2022, down -67.11% from previous year.
L&C Bio Co., Ltd reported an annual net income of 13.81 Billion KRW in 2021, up 27.76% from previous year.
L&C Bio Co., Ltd reported a quarterly net income of 1.06 Billion KRW for 2024 Q2, down -31.37% from previous quarter.
L&C Bio Co., Ltd reported a quarterly net income of 599.84 Million KRW for 2023 Q1, down -67.14% from previous quarter.

Annual Net Income Chart of L&C Bio Co., Ltd (2023 - 2015)

Historical Annual Net Income of L&C Bio Co., Ltd (2023 - 2015)

Year	Net Income	Net Income Growth
2023	48.36 Billion KRW	964.24%
2022	4.54 Billion KRW	-67.11%
2021	13.81 Billion KRW	27.76%
2020	10.81 Billion KRW	49.15%
2019	7.25 Billion KRW	39.22%
2018	5.2 Billion KRW	38.76%
2017	3.75 Billion KRW	89.44%
2016	1.98 Billion KRW	64.81%
2015	1.2 Billion KRW	0.0%

Year	Net Income	Net Income Growth
2024 Q1	1.55 Billion KRW	145.56%
2024 Q2	1.06 Billion KRW	-31.37%
2023 Q1	599.84 Million KRW	-67.14%
2023 Q4	-3.4 Billion KRW	-106.84%
2023 FY	48.36 Billion KRW	964.24%
2023 Q2	1.37 Billion KRW	128.44%
2023 Q3	49.79 Billion KRW	3534.06%
2022 Q2	1.13 Billion KRW	-9.85%
2022 FY	4.54 Billion KRW	-67.11%
2022 Q4	1.82 Billion KRW	473.15%
2022 Q3	318.47 Million KRW	-72.01%
2022 Q1	1.26 Billion KRW	-84.92%
2021 Q2	1.78 Billion KRW	-6.12%
2021 Q3	1.75 Billion KRW	-1.53%
2021 Q4	8.37 Billion KRW	376.57%
2021 FY	13.81 Billion KRW	27.76%
2021 Q1	1.9 Billion KRW	-65.94%
2020 Q3	1.88 Billion KRW	7.85%
2020 Q4	5.57 Billion KRW	196.47%
2020 FY	10.81 Billion KRW	49.15%
2020 Q1	1.6 Billion KRW	-18.84%
2020 Q2	1.74 Billion KRW	8.6%
2019 Q4	1.97 Billion KRW	20.19%
2019 FY	7.25 Billion KRW	39.22%
2019 Q3	1.64 Billion KRW	-19.82%
2019 Q2	2.05 Billion KRW	30.9%
2019 Q1	1.56 Billion KRW	27.13%
2018 Q2	1.71 Billion KRW	36.6%
2018 Q1	1.25 Billion KRW	0.0%
2018 Q3	1 Billion KRW	-41.53%
2018 Q4	1.23 Billion KRW	23.08%
2018 FY	5.2 Billion KRW	38.76%
2017 FY	3.75 Billion KRW	89.44%
2016 FY	1.98 Billion KRW	64.81%
2015 FY	1.2 Billion KRW	0.0%

Peer Net Income Comparison of L&C Bio Co., Ltd

Name	Net Income	Net Income Difference
Osang Healthcare Co.,Ltd	116.43 Billion KRW	58.466%
InBody Co.,Ltd	36.72 Billion KRW	-31.692%
Curexo Inc.	-4.85 Billion KRW	1095.898%
Seegene, Inc.	669.01 Million KRW	-7128.724%
i-SENS, Inc.	3.7 Billion KRW	-1203.861%
Ray Co., Ltd.	-2.14 Billion KRW	2353.207%
Gencurix Inc.	-19.26 Billion KRW	351.095%
Sugentech Inc.	-17.23 Billion KRW	380.544%